Not a good buy right now: trend is bearish and momentum is still deteriorating (negative, expanding MACD histogram).
Price (~62) is trading below the first support level (S1 62.733) and only slightly above S2 (62.01), which implies weak demand and elevated risk of another leg down.
No proprietary Intellectia buy signals (AI Stock Picker / SwingMax), no fresh news catalysts, and latest quarter shows revenue growth but profitability deterioration.
For an impatient buyer looking to enter immediately, the setup does not justify a buy; best call is to avoid/exit rather than try to catch a falling move.
Technical Analysis
Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating both long- and short-term downtrend alignment.
Momentum: MACD histogram -0.0646 below zero and negatively expanding → bearish momentum strengthening.
RSI(6): 28.914 (near oversold); this can support a short-term bounce, but it is not a trend-reversal signal by itself.
Key levels:
Resistance: Pivot 63.903, then R1 65.074 / R2 65.797 (likely supply zones if price rebounds).
Support: S1 62.733 (already broken), S2 62.01 (immediate line in the sand).
Pattern-based expectation: Similar pattern cohort implies modest upside probabilities (next month +8.05% scenario), but near-term edge is small and not supported by current momentum.
Downtrend is intact (bearish moving average stack) and MACD momentum is worsening.
Price is below S1 support, suggesting sellers remain in control.
No news in the past week → no event-driven catalyst to reverse sentiment.
Broader tape is risk-off (S&P 500 -1.2% during regular market), which can pressure thin/less-liquid names disproportionately.
Profitability deterioration (net loss and margin compression) undermines confidence in a near-term re-rating.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 23,686,671 (+17.21% YoY) → top-line growth is positive.
Net Income: -521,828 (down -113.35% YoY) → moved deeper into losses.
EPS: -4.48 (down -113.40% YoY) → earnings trend is worsening.
Gross Margin: 27.54 (down -30.01% YoY) → significant margin compression, a key negative for near-term valuation support.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target data provided (likely limited coverage).
Wall Street-style pro view (inferred from fundamentals): revenue growth is a plus and could support a turnaround narrative if margins recover.
Wall Street-style con view (inferred from fundamentals/technicals): accelerating losses and sharply lower margins plus a clear bearish trend make the risk/reward unattractive right now.
Trading activity context: Hedge funds neutral (no significant last-quarter trend) and insiders neutral (no significant last-month trend) → no strong “smart money” confirmation.
Wall Street analysts forecast NEN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NEN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
